Milagros Dalgir Samaniego-Picota MD FASN FACP FAST
Glomerular Disease, Kidney & Pancreas Transplantation
Medical Director of Kidney and Kidney Pancreas Transplantation Henry Ford Transplant Institute
Join to View Full Profile
313 W Country Club RdSte 12Roswell, NM 88201
Phone+1 575-627-5828
Fax+1 575-627-5835
Dr. Samaniego-Picota is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Nephrology, 1994 - 1997
Baylor College of MedicineResidency, Internal Medicine, 1990 - 1994
Universidad de Panama Faculty of MedicineClass of 1984
Certifications & Licensure
MI State Medical License 2009 - 2026
NM State Medical License 2024 - 2025
MD State Medical License 1996 - 2013
WI State Medical License 2004 - 2013
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Fellow (ASNF) American Society of Nephrology
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant Start of enrollment: 2016 May 20
- Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients Start of enrollment: 2019 Oct 14
- Trifecta-Kidney cfDNA-MMDx Study Start of enrollment: 2019 Dec 01
Publications & Presentations
PubMed
- 3 citationsSubthreshold rejection activity in many kidney transplants currently classified as having no rejection.Philip F Halloran, Katelynn S Madill-Thomsen, Georg Böhmig, Jonathan Bromberg, Klemens Budde
American Journal of Transplantation. 2025-01-01 - 1 citationsA randomized, placebo-controlled, dose-escalation phase I/II multicenter trial of low-dose cidofovir for BK polyomavirus nephropathy.Hannah Imlay, John W Gnann Jr, James Rooney, V Ram Peddi, Alexander C Wiseman
Transplant Infectious Disease. 2024-12-01 - 9 citationsElevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant.Jonathan S Bromberg, Suphamai Bunnapradist, Milagros Samaniego-Picota, Sanjiv Anand, Erik Stites
Transplantation. 2024-09-01
Professional Memberships
- Fellow
- Member
- Fellow
- The Transplantation SocietyMember
- American Society of TransplantationFellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
